T. Rowe Price Investment Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $119M | Sell |
1,594,867
-600,702
| -27% | -$44.8M | 0.08% | 248 |
|
|
2025
Q1 | $140M | Sell |
2,195,569
-358,245
| -14% | -$22.8M | 0.09% | 222 |
|
|
2024
Q4 | $199M | Sell |
2,553,814
-296,823
| -10% | -$23.2M | 0.12% | 179 |
|
|
2024
Q3 | $229M | Buy |
2,850,637
+1,207,696
| +74% | +$97.1M | 0.14% | 168 |
|
|
2024
Q2 | $136M | Buy |
1,642,941
+424,730
| +35% | +$35.1M | 0.09% | 233 |
|
|
2024
Q1 | $104M | Buy |
1,218,211
+125,912
| +12% | +$10.7M | 0.06% | 287 |
|
|
2023
Q4 | $93.4M | Buy |
1,092,299
+245,382
| +29% | +$21M | 0.06% | 285 |
|
|
2023
Q3 | $75.9M | Buy |
+846,917
| New | +$75.9M | 0.05% | 297 |
|